National Pension Service
SRPT icon

National Pension Service’s Sarepta Therapeutics SRPT Stock Holding History

National Pension Service’s Portfolio SRPT Stock Details SRPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-124,922
Closed -$17.9M – 490
2020
Q3 		$17.9M Hold
124,922
– – 0.05% 420
2020
Q2 		$20M Buy
+124,922
New +$17M 0.06% 384

Other funds holding SRPT

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

National Pension Service's SRPT Position: Q4 2020 in Review

National Pension Service sold out of Sarepta Therapeutics (SRPT) in Q4 2020, closing a stake of 124,922 shares — an estimated $17.9M sold.

National Pension Service first reported a position in SRPT in Q2 2020 and held it in 2 quarters. The position peaked at $20M in Q2 2020. 454 funds tracked by Wall St. Rank hold SRPT as of Q4 2020.

  • National Pension Service reported no remaining Sarepta Therapeutics position as of Q4 2020 after selling out during the quarter.
  • National Pension Service sold 124,922 Sarepta Therapeutics shares in Q4 2020, an estimated $17.9M.
  • National Pension Service first reported a position in Sarepta Therapeutics in Q2 2020 and held it in 2 quarters.
  • National Pension Service's Sarepta Therapeutics position peaked at $20M in Q2 2020.
  • 454 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q4 2020.

Based on National Pension Service's 13F filing for Q4 2020, filed 19 Feb 2021.